| RS1553479603 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS1553481071 |
SCN9A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1553482689 |
TSGA10
|
Health Risk |
Pathogenic |
Spermatogenic failure 26, Spermatogenic failure 26 |
| RS1553482872 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553484094 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis 1, Nephronophthisis |
| RS1553484601 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1553484602 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553485330 |
TTN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553486684 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1553487838 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553487942 |
NFE2L2
|
Health Risk |
Pathogenic |
Immunodeficiency, developmental delay |
| RS1553487947 |
NFE2L2
|
Health Risk |
Pathogenic |
Immunodeficiency, developmental delay |
| RS1553488015 |
NFE2L2
|
Health Risk |
Pathogenic/Likely pathogenic |
Colorectal cancer, Immunodeficiency |
| RS1553488049 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553488312 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553488759 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1553488882 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553489404 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553490323 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553490574 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553491169 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553491220 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553491793 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553492053 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553492481 |
SCN9A
|
Health Risk |
Pathogenic |
— |
| RS1553493234 |
SLC40A1
|
Health Risk |
Pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1553493479 |
SLC40A1
|
Health Risk |
Pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1553493481 |
SLC40A1
|
Health Risk |
Pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1553493553 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1553493639 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553493871 |
PNPT1
|
Health Risk |
Likely pathogenic |
— |
| RS1553494286 |
SLC40A1
|
Health Risk |
Pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1553494436 |
STAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS1553495048 |
SCN9A
|
Health Risk |
Likely pathogenic |
Primary erythromelalgia, Channelopathy-associated congenital insensitivity to pain |
| RS1553495104 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553495140 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553495184 |
STAT1
|
Health Risk |
Pathogenic |
— |
| RS1553495699 |
SLC40A1
|
Health Risk |
Pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1553495983 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1553496051 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1553496156 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553496195 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553496358 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1553496413 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1553496847 |
HECW2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553496850 |
STAT1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Immunodeficiency 31B |
| RS1553497886 |
STAT1
|
Health Risk |
Likely pathogenic |
— |
| RS1553498017 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1553498582 |
SPR
|
Health Risk |
Pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dopa-responsive dystonia due to sepiapterin reductase deficiency |
| RS1553498611 |
SPR
|
Health Risk |
Likely pathogenic |
— |
| RS1553498948 |
LNPK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum |
| RS1553499757 |
HIBCH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxyisobutyryl-CoA hydrolase deficiency, Inborn genetic diseases |
| RS1553500497 |
PYCR2
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS1553500506 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553500574 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553500862 |
TUBA3D
|
Health Risk |
Pathogenic |
Keratoconus 9, Keratoconus 9 |
| RS1553501227 |
TTN
|
Health Risk |
Likely pathogenic |
Myopathy, myofibrillar |
| RS1553501572 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1553501873 |
HIBCH
|
Health Risk |
Likely pathogenic |
Neurodegeneration due to 3-hydroxyisobutyryl coenzyme A hydrolase deficiency, Neurodegeneration due to 3-hydroxyisobutyryl coenzyme A hydrolase deficiency |
| RS1553501889 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553502168 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553503113 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553503175 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS1553503177 |
NDUFS1
|
Health Risk |
Pathogenic |
— |
| RS1553503200 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1553503201 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553503473 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1553504273 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1553504456 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS1553504889 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553505302 |
HIBCH
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553505929 |
PDE11A
|
Health Risk |
Likely pathogenic |
— |
| RS1553506164 |
HIBCH
|
Health Risk |
Likely pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS1553506317 |
ALS2
|
Health Risk |
Pathogenic |
— |
| RS1553506530 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS1553506655 |
NDUFS1
|
Health Risk |
Pathogenic |
— |
| RS1553506938 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507155 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553507167 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1553507180 |
COL3A1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553507183 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553507249 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553507265 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507274 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507345 |
COL3A1
|
Health Risk |
Likely pathogenic |
Aortic dissection, Aortic dissection |
| RS1553507389 |
SATB2
|
Health Risk |
Pathogenic |
SATB2-related disorder, SATB2-related disorder |
| RS1553507391 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1553507432 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507557 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507574 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553507614 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507751 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Dilated cardiomyopathy 1G |
| RS1553507793 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553507863 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553507867 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553507953 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1553507955 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553507991 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1553508025 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553508039 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |